Back to trial details

Intake questionnaire

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Applying to University of Kansas Medical Center · Kansas City, Kansas

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 65 years old?
2. Have you been diagnosed with Systemic Lupus Erythematosus?
3. Are you able to travel to Kansas City for study visits?